Zeal Capital Partners

Zeal Capital Partners writes early checks against an explicit thesis: that the largest investment opportunities sit at the intersection of health and wealth gaps and that the founders best placed to solve those problems are often the ones traditional venture has overlooked. From its Washington base, the firm backs early-stage tech-enabled healthcare companies whose products serve populations and use cases that mainstream investors have historically priced poorly. The work is strategic rather than philanthropic, and the bar for returns is the same as for any venture firm.

The thesis is digital health and tech-enabled care delivery, with portfolio examples including Viu Health and Auxa Health that sit squarely in the category of accessible, technology-mediated care. AI focus is real and reflects the broader direction of digital health, with the working preference for products where the model is doing genuine work in clinical or operational decision-making rather than marketing positioning. Founders pursuing pure enterprise health IT or pharma plays are usually a less natural fit.

Checks fall in the one to five million dollar range, deployed across pre-seed, seed, and Series A. The firm participates and leads depending on the round, and the leverage on the cap table is a partner with a clear strategic view of the inclusive-finance and inclusive-health categories and a network that reflects that focus. Geography is centered on the United States, with Washington as the operating base and engagement across the country.

The firm is built around a small, focused team rather than a large generalist platform, and its identity is heavily shaped by its inclusive-investment thesis. Founders interact with the principals rather than working through an associate-led process.

The approach is thesis-driven and operationally engaged. The firm is most useful on questions of how to design a product that genuinely serves the population it claims to serve, how to structure pricing and distribution for buyers like Medicaid managed care and self-insured employers serving frontline workforces, and how to navigate the long, often-messy work of selling into healthcare systems that are not always set up to buy the product. Process is direct, with diligence focused on the specifics of the customer and the unit economics. Follow-on participation across rounds is part of the firm’s strategy. For tech-enabled healthcare founders building for under-served populations and looking for a partner whose thesis is consistent with that work, the proposition is direct.